Subscribe To
Jpmorgan ceo jamie dimon arrives at capitol hill to meet with house democrats
CNBC's Eamon Javers and JPMorgan's Jamie Dimon on 'Halftime Report' to discuss meeting with democrats on Capitol Hill, Dimon's presidential ...
June 6, 2023, 1:37 pm
Bellerophon (blph) down 87% as lung disease candidate fails
Bellerophon's (BLPH) shares fall as a late-stage study of INOpulse to treat fibrotic interstitial lung disease fails to meet its primary endpoint....
June 6, 2023, 1:15 pm
U.s. wide-moat stocks on sale - the june 2023 heat map
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in ...
June 6, 2023, 12:25 pm
Why is t2 biosystems (ttoo) stock up 17% today?
T2 Biosystems (NASDAQ: TTOO ) stock is rising higher on Tuesday after the company revealed its submission for a Breakthrough Device Designation for it...
June 6, 2023, 8:28 am
Robert f. kennedy jr. silent on bitcoin and cbdc during twitter talk with elon musk
Tesla CEO and Twitter owner Elon Musk hosted a conversation with presidential candidate Robert F. Kenne...
June 6, 2023, 12:59 am
Vizsla silver: a strong candidate for expected bull market
Vizsla Silver Corp. is a good candidate to profit from the next bull market in precious metals as the e...
June 6, 2023, 12:34 am
2 tech stocks to buy for strong eps growth
Cloud computing provider ServiceNow (NOW) and internet infrastructure services provider Verisign (VRSN) are two worthy ...
June 6, 2023, 12:28 am
In one chart: as mike pence, chris christie and doug burgum enter the race, here are the republicans running for president in 2024
This is MarketWatch’s list of the 2024 Republican presidential contenders and the status of their candid...
June 5, 2023, 7:03 pm
Why shares of day one pharmaceuticals are up monday
Day One has begun a rolling NDA for its candidate DAY101 as a monotherapy for relapsed or progressive p...
June 5, 2023, 12:30 pm
Pro-bitcoin candidate robert kennedy jr. ‘can and will’ beat trump, desantis: jack dorsey
Block co-founder and CEO Jack Dorsey has backed Bitcoin advocate Robert F. Kennedy Jr. for his 2024 presidential run. Read Full Story The post Pro-Bit...
June 5, 2023, 9:59 am
Stock split watch: is costco next?
With a share price of around $500, Costco is a good candidate for a stock split. Costco has had three s...
June 4, 2023, 9:14 am
Up 48% in 2023, is this biotech stock a buy?
Krystal Biotech recently reached an important milestone with the approval of its lead candidate Vyjuvek...
June 3, 2023, 8:30 am
Lava (lvtx) up on j&j's (jnj) cancer study candidate selection
LAVA's (LVTX) shares soar as partner J&J (JNJ) selects a lead candidate for development in clinical stu...
June 2, 2023, 12:09 pm
Aclaris therapeutics to participate in two june healthcare investor conferences
WAYNE, Pa., June 02, 2023 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on develo...
June 2, 2023, 11:00 am
Biontech says drug from oncoc4 partnership shows promise in mid-stage trial
BioNTech said on Friday that a new cancer immunotherapy candidate that it is working on with U.S. partn...
June 2, 2023, 6:48 am
Ishares msci indonesia etf: low valuation and economic restructuring
Indonesia is the second candidate, after India, for the title of Asia's best emerging economy. Buying a...
June 2, 2023, 4:58 am
Netapp is gearing up to breakout after earnings top estimates
NetApp, Inc. NASDAQ: NTAP reported earnings for their fourth quarter ending April 2023 yesterday after the close and topped consensus estimates. While...
June 1, 2023, 8:31 am
Pyxis (pyxs) up on advancing cancer therapy candidates
Pyxis' (PYXS) shares rise as the company advances its phase I candidates, PYX-106 and PYX-201, for chal...
May 31, 2023, 10:45 am
Biomx to present part 1 data from phase 1b/2a study evaluating bx004 for the treatment of chronic pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis during late-breaking scie
CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 31, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clini...
May 31, 2023, 3:00 am
Biomx to present part 1 data from phase 1b/2a study evaluating bx004 for the treatment of chronic pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis during late-breaking scie
CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 31, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clini...
May 31, 2023, 3:00 am